The role of conservative surgery in the treatment of Papillar thyroid microcarcinoma at Thong Nhat Hospital
Main Article Content
Abstract
Background: Although very common and full of the dangers of cancer, many recent studies have noted that small papillary thyroid carcinoma progresses slowly and there are cases where conservative thyroidectomy gives good results even though it is not from the perspective of radical surgery. In Vietnam, there is currently little information on this issue. What are the results of surgical treatment in these cases?.
Objectives and method: the descriptive cross-sectional study of 49 cases of small papillary thyroid cancer, evaluation of surgical results and mid-term follow-up from 01/2022 to 01/2025 at Thong Nhat Hospital.
Results and discussion: The mean age was 45.1. The male/female ratio was 1/3.9(p=0.003). Multiple tumors were 22.4%. Tumors invading the capsule were 16.3%. Neck lymph node metastasis was 16.3%. There was no distant metastasis. Stage I according to cTNM was 91.8%. The total lobectomy and isthmus group had 34 cases; the total thyroidectomy group had 15 cases. In the two groups: hypothyroidism after 6 months of surgery was 36.7%, 30.6% (p=0.002); 12 months was 06.1%, 28.6% (p=0.001). In each group: total lobectomy with isthmus, postoperative hypothyroidism at 6 months and 12 months was 36.7% and 06.1% (p=0.002); Total thyroidectomy, the rate was 30.6% and 28.6% (p=0.52). 01 case of hoarseness, 01 thoracic duct rupture, 02 cases of tetany. There was no surgery-related death. Recurrence was 2% in 24-month follow-up.
Conclusion: Microcarcinoma papillary thyroid cancer is mainly stage 1. Surgery gives good results. There is no surgery-related mortality. Hypothyroidism after total lobectomy is lower than total thyroidectomy and recovery after 12 months. low recurrence rate in 24 months follow-up.
Article Details
Keywords
thyroid cancer, papillary, microcarcinoma
References
2. Laura Boucai et al. Thyroid Cancer: A Review. JAMA. 2024 Feb 6;331(5):425-435.
3. Ferlay J, Ervik M, et al. Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from URL: https://gco.iarc.who.int/today, accessed. 2024
4. American thyroid association. Microcarcinomas of the Thyroid Gland [online]. 2025 [cited 2025 Jan 14]; [4 screens]. Available from: URL: https://www.thyroid.org/microcarcinomas-thyroid-gland.htm
5. Hay I.D., Grant C.S., Van Heerden J.A., Goellner J.R. Papillary thyroid microcarcinoma: a study of 535 cases observed in a 50-year period. Surgery 1992, 112 (6), pp.1139-1146; discussion pp.1146-1137.
6. Baloch ZW, Asa SL, Barletta et all. Overview of the 2022 WHO Classification of Thyroid Neoplasms. Endocrine Pathology 2022, 33:27-63
7. Alexander B Olawaiye, Thomas P Baker, M Kay Washington et al. The new (Version 9) American Joint Committee on Cancer tumor, node, metastasis staging for cervical cancer. CA Cancer J Clin 2021 Jul;71(4):287-298.
8. Bộ y tế. Về việc ban hành tài liệu chuyên môn hướng dẫn chẩn đoán và điều trị bệnh béo phì. Quyết định 2892/QĐ-BYT 2022.
9. Mao Y, Xing M. Recent incidences and differential trends of thyroid cancer in the USA. Endocr Relat Cancer. 2016; 23(4): 313-322.
10. Hearshman J.M. Thyroid gland. Endocrine, neuroendocrine treatment 7th edd 2005. EDW.B Saunders Company.P 458- 759.
11. Zhang C, Li Y, Li J, Chen X. Total thyroidectomy versus lobectomy for papillary thyroid cancer: A systematic review and meta-analysis. Medicine (Baltimore). 2020; 99(6): e19073.
12. Vanderpump MPJ. The epidemiology of thyroid disease. Br Med Bull. 2011;99:39–51.